Literature DB >> 34697414

Optimal model establishment of whole-process management data for CAR-T therapy in China-how should this be done?

Xiaolei Li1,2, Hanren Dai2, Xian Li3, Ping Li4, Wenbin Qian5, Aibin Liang6, Weidong Han7.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34697414      PMCID: PMC8752796          DOI: 10.1038/s41423-021-00789-3

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  2 in total

1.  Parkinson pipeline pare back.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2021-03       Impact factor: 84.694

2.  Blood-brain barrier-traversing biologic secures regulatory approval, in Japan.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2021-04-13       Impact factor: 84.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.